AFT Pharmaceuticals is highly selective about the products it brings to the Australasian market – and its eyecare portfolio exemplifies...
Read moreGlaukos has commenced Phase 2 trials of two investigational cream-based drug candidates that are applied to the eyelids to treat...
Read morePharmaceutical firm Seqirus has announced that its new therapy Ikervis is now available via the Pharmaceutical Benefits Scheme (PBS), making...
Read morePharmaceutical company Seqirus has announced that preservative-free dry eye therapy Cationorm is now accessible via the Pharmaceutical Benefits Scheme (PBS)...
Read moreAllergan has secured regulatory approval for an alternative product to address a Prednefrin Forte shortage in Australia. The company confirmed...
Read moreThe Therapeutic Goods Administration (TGA) has confirmed a shortage of Prednefrin Forte 10mL eye drops in Australia, which isn't expected...
Read moreNovartis has announced positive findings from its the Phase 3 trial assessing the efficacy and safety of Beovu (brolucizumab) to...
Read moreAFT Pharmaceuticals has officially introduced NovaTears + Omega-3 eye drops in Australia, and provided new details about the formulation. Developed...
Read moreASX-listed AFT Pharmaceuticals has expanded its therapeutics range with a new dry eye therapy containing Omega-3. The company has introduced...
Read moreAllergan’s Optive eye drops range, available in five varieties, includes Optive Advanced Preservative Free and Optive Advanced drops, which offer...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited